News Snapshot:
Representative Image. BCCL This comes barely 24 hours after on Monday The Lancet only published that a Covid-19 vaccine developed by scientists at the Oxford University produces strong immune responses in both parts of the immune system, showed results of Phase I/II trial. The results from the Chinese trial provide data from a wider group of participants than the phase 1 trial, which was published in May. Phase 1 trial involved 108 healthy adults and it demonstrated promising results. These cells then produce the spike protein and travel to the lymph nodes where the immune system creates antibodies that will...
